Biontech Se ADR (BNTX)

$96.00 +0.26 (0.28%)
Market Cap 21.56B
Revenue (ttm) 2.98B
Net Income (ttm) -719.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.18%
Debt to Equity Ratio 0.01
Volume 1,185,000
Avg Vol 957,816
Day's Range N/A - N/A
Shares Out 225.18M
Stochastic %K 20%
Beta 1.30
Analysts Strong Sell
Price Target $137.42

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
taxplanr
taxplanr Dec. 12 at 2:37 AM
The cancer cure cover ups being exposed are everywhere $BNTX $MRNA $PFE $BMY https://www.thefocalpoints.com/p/dandelion-root-extract-kills-95-of
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 11 at 11:00 PM
$MRNA $NVAX $PFE $BNTX
1 · Reply
RunnerSignals
RunnerSignals Dec. 11 at 8:16 PM
Stock Upgrades Today $ABBV $ALAB $ALB $BNTX $CL on the move with upgrades flying in https://stocksrunner.com/news/2025-12-11-stock-upgrades-today-show-top-picks
0 · Reply
kevin_davis07f
kevin_davis07f Dec. 11 at 7:53 PM
$BNTX Mainz Biomed is coiled so tight that the distance from the base at 1.05 to the top of the recent range at 1.20 is almost +14%, and a microcap with this float can print that in one clean trend day
0 · Reply
taxplanr
taxplanr Dec. 11 at 3:48 PM
non small cell lung cancer has a very good drug treatment $BNTX Just ask the Mayo Clinic https://www.mayoclinic.org/drugs-supplements/lorlatinib-oral-route/description/drg-20452266
0 · Reply
taxplanr
taxplanr Dec. 11 at 2:45 PM
$BNTX maybe it was just a bad time to take on more overhead and operational losses with $CVAC 🤔
0 · Reply
ChartHunter88
ChartHunter88 Dec. 11 at 1:05 PM
$BNTX vaccine and immunotherapy story, still a volatility magnet when big headlines hit 🧬
0 · Reply
Robert321
Robert321 Dec. 11 at 12:17 PM
$BNTX last days i bought a few hundred, the most undervalued stock with lot´s of money and a really great pipeline. just a small patience
0 · Reply
Robert321
Robert321 Dec. 11 at 12:13 PM
$BNTX Reuters: * Biontech SE BNTX: Berenberg erhöht Kursziel auf $155 von $150
0 · Reply
taxplanr
taxplanr Dec. 11 at 12:46 AM
$BNTX $MRNA $PFE Former CDC Director Redfield live tomorrow after calling for removal of the COVID shots https://kirschsubstack.com/p/former-cdc-director-robert-redfield?utm_source=post-email-title&publication_id=548354&post_id=181282820&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
Latest News on BNTX
BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart

Dec 9, 2025, 5:54 PM EST - 2 days ago

BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

Dec 9, 2025, 7:00 AM EST - 2 days ago

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

BMY

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Dec 6, 2025, 3:30 PM EST - 5 days ago

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

Dec 3, 2025, 9:01 AM EST - 8 days ago

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

CVAC

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 10 days ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

MRNA NVAX PFE

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 10 days ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

MRNA NVAX PFE

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Nov 26, 2025, 7:30 AM EST - 15 days ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Nov 17, 2025, 6:17 PM EST - 24 days ago

BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Nov 13, 2025, 5:20 PM EST - 4 weeks ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

PFE

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

Nov 13, 2025, 11:10 AM EST - 4 weeks ago

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

PFE

BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 4 weeks ago

BioNTech says collaboration with Pfizer remains unchanged

PFE

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold

Nov 3, 2025, 1:44 PM EST - 5 weeks ago

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:46 PM EST - 5 weeks ago

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

Nov 3, 2025, 10:29 AM EST - 5 weeks ago

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

BMY

BioNTech lifts 2025 revenue guidance on BMS partnership payment

Nov 3, 2025, 6:47 AM EST - 5 weeks ago

BioNTech lifts 2025 revenue guidance on BMS partnership payment

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

Nov 3, 2025, 6:45 AM EST - 5 weeks ago

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 28, 2025, 7:45 AM EDT - 6 weeks ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

Oct 27, 2025, 7:45 AM EDT - 6 weeks ago

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Oct 22, 2025, 6:45 AM EDT - 7 weeks ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 7 weeks ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

MRNA

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

Oct 8, 2025, 10:15 AM EDT - 2 months ago

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

CRSP

BioNTech SE, InstaDeep Ltd - Special Call

Oct 1, 2025, 6:52 PM EDT - 2 months ago

BioNTech SE, InstaDeep Ltd - Special Call

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

Oct 1, 2025, 6:13 PM EDT - 2 months ago

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 23, 2025, 6:45 AM EDT - 2 months ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Why BioNTech Stock Bumped Higher Today

Sep 22, 2025, 6:45 PM EDT - 2 months ago

Why BioNTech Stock Bumped Higher Today

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 2 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

Why BioNTech Stock Sank by More Than 7% Today

Sep 12, 2025, 6:19 PM EDT - 3 months ago

Why BioNTech Stock Sank by More Than 7% Today

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

Sep 12, 2025, 1:37 PM EDT - 3 months ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

Sep 8, 2025, 2:01 PM EDT - 3 months ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BMY

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

Sep 8, 2025, 11:05 AM EDT - 3 months ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 11:00 AM EDT - 3 months ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Pfizer, partner BioNTech say updated COVID shot shows better immune response

Sep 8, 2025, 7:02 AM EDT - 3 months ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

PFE

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Sep 8, 2025, 6:45 AM EDT - 3 months ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

PFE

Why BioNTech Stock Crushed the Market Today

Sep 5, 2025, 4:41 PM EDT - 3 months ago

Why BioNTech Stock Crushed the Market Today

BioNTech, Duality score initial trial win with breast cancer precision drug

Sep 5, 2025, 5:13 AM EDT - 3 months ago

BioNTech, Duality score initial trial win with breast cancer precision drug

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 3 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Aug 27, 2025, 12:50 PM EDT - 3 months ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

PFE

CureVac settles patent dispute litigation with Pfizer and BioNTech

Aug 7, 2025, 9:00 PM EDT - 4 months ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 5, 2025, 1:36 PM EDT - 4 months ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:56 PM EDT - 4 months ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 10:32 AM EDT - 4 months ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 7:01 AM EDT - 4 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:52 AM EDT - 4 months ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 4, 2025, 6:45 AM EDT - 4 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Aug 1, 2025, 4:51 PM EDT - 4 months ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 4 months ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 4 months ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Aug 1, 2025, 5:59 AM EDT - 4 months ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Pandemic darlings Moderna, BioNTech are now on two different paths

Jul 31, 2025, 7:00 AM EDT - 4 months ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 4 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

taxplanr
taxplanr Dec. 12 at 2:37 AM
The cancer cure cover ups being exposed are everywhere $BNTX $MRNA $PFE $BMY https://www.thefocalpoints.com/p/dandelion-root-extract-kills-95-of
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 11 at 11:00 PM
$MRNA $NVAX $PFE $BNTX
1 · Reply
RunnerSignals
RunnerSignals Dec. 11 at 8:16 PM
Stock Upgrades Today $ABBV $ALAB $ALB $BNTX $CL on the move with upgrades flying in https://stocksrunner.com/news/2025-12-11-stock-upgrades-today-show-top-picks
0 · Reply
kevin_davis07f
kevin_davis07f Dec. 11 at 7:53 PM
$BNTX Mainz Biomed is coiled so tight that the distance from the base at 1.05 to the top of the recent range at 1.20 is almost +14%, and a microcap with this float can print that in one clean trend day
0 · Reply
taxplanr
taxplanr Dec. 11 at 3:48 PM
non small cell lung cancer has a very good drug treatment $BNTX Just ask the Mayo Clinic https://www.mayoclinic.org/drugs-supplements/lorlatinib-oral-route/description/drg-20452266
0 · Reply
taxplanr
taxplanr Dec. 11 at 2:45 PM
$BNTX maybe it was just a bad time to take on more overhead and operational losses with $CVAC 🤔
0 · Reply
ChartHunter88
ChartHunter88 Dec. 11 at 1:05 PM
$BNTX vaccine and immunotherapy story, still a volatility magnet when big headlines hit 🧬
0 · Reply
Robert321
Robert321 Dec. 11 at 12:17 PM
$BNTX last days i bought a few hundred, the most undervalued stock with lot´s of money and a really great pipeline. just a small patience
0 · Reply
Robert321
Robert321 Dec. 11 at 12:13 PM
$BNTX Reuters: * Biontech SE BNTX: Berenberg erhöht Kursziel auf $155 von $150
0 · Reply
taxplanr
taxplanr Dec. 11 at 12:46 AM
$BNTX $MRNA $PFE Former CDC Director Redfield live tomorrow after calling for removal of the COVID shots https://kirschsubstack.com/p/former-cdc-director-robert-redfield?utm_source=post-email-title&publication_id=548354&post_id=181282820&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
bullwink
bullwink Dec. 10 at 9:45 PM
$BNTX Market cap 22 billion. Cash 19 billion Massive Oncology/vaccine pipeline with 26 Phase 3 and Phase 2/3 Indications 30+ Phase 2 and Phase 1 Indications Plus, you get well-established Vaccine franchise with 2.6 billion annual revenues Undervalued is a gross understatement. It may keep going down due to momentum but at some point, market will come to its senses.
0 · Reply
isabellahart99
isabellahart99 Dec. 10 at 7:13 PM
$BNTX large cap biotech, if sentiment turns risk-on this can reclaim trend confirmation levels
1 · Reply
leila_signals
leila_signals Dec. 10 at 5:56 PM
$BNTX biotech large cap, if sentiment turns risk-on this can reclaim trend confirmation levels
0 · Reply
chelfen
chelfen Dec. 10 at 4:37 PM
$BNTX there will be steady stream of good news related to the ongoing phase 1/2/3 trials during next year. Patience is the key.
0 · Reply
MS1974
MS1974 Dec. 10 at 3:52 PM
$MRNA hand in hand $BNTX 👈
0 · Reply
taxplanr
taxplanr Dec. 10 at 3:49 PM
COVID jab was always a hoax $BNTX $MRNA $PFE https://resistthemainstream.com/tech-mafia-wife-admits-we-were-klaus-schwabs-useful-idiots/?utm_source=truthsocial
1 · Reply
taxplanr
taxplanr Dec. 10 at 3:07 PM
Another success story against Lung cancer with Ivermectin $BNTX $GSK https://makisw.substack.com/p/ivermectin-fenbendazole-artemisia?utm_source=post-email-title&publication_id=1385328&post_id=181222821&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Dec. 10 at 2:50 PM
Dims are going to out their RINO'S with this move $PFE $MRNA $BNTX https://www.foxnews.com/politics/house-democrat-introduces-impeachment-articles-against-rfk-jr
1 · Reply
Robert321
Robert321 Dec. 10 at 12:29 PM
$BNTX Buyrating: https://seekingalpha.com/article/4851780-biontech-strong-buy-after-part-1-success-of-next-gen-anti-ctla-4-gotistobart
0 · Reply
AlertsAndNews
AlertsAndNews Dec. 10 at 4:13 AM
$MRNA $PFE $BNTX FDA Probes Potential Links Between Covid-19 Vaccines and Adult Deaths – Bloomberg The FDA has opened an investigation into whether Covid-19 vaccines may be connected to deaths in adults, federal health officials said. An HHS spokesperson noted the agency is reviewing cases across multiple age groups as part of a broader safety assessment.
0 · Reply
taxplanr
taxplanr Dec. 10 at 1:16 AM
$BNTX $MRNA $PFE help get the child killer revoked https://childrenshealthdefense.org/defender/chd-asks-fda-to-revoke-covid-vaccine-licenses-petition/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20251209
0 · Reply
SimpleWinningSetups
SimpleWinningSetups Dec. 9 at 10:06 PM
Hedge Alert Live - Protect Your Portfolio Contract: $BNTX $95.00 Put · DEC 19, 2025 Exp Entry Price: $2.25 - $2.35 Exit Price Target: $4.79 Profit Margin: +113% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply